40154-84-5 Usage
Uses
Used in Pharmaceutical Synthesis:
(S)-1-(pyridin-3-yl)ethanamine dihydrochloride is used as a key intermediate for the synthesis of various pharmaceuticals, such as antihistamines, antipsychotics, and antidepressants. Its chiral amine structure plays a vital role in the development of these medications, contributing to their efficacy and therapeutic properties.
Used in Agrochemical Production:
In the agrochemical industry, (S)-1-(pyridin-3-yl)ethanamine dihydrochloride is employed as a reagent in the synthesis of various agrochemicals. Its unique chemical properties allow for the creation of compounds that can be used in the development of pesticides, herbicides, and other agricultural products to enhance crop protection and yield.
Used in Asymmetric Catalysis:
(S)-1-(pyridin-3-yl)ethanamine dihydrochloride has been studied for its potential application in asymmetric catalysis. Its chiral nature makes it a promising candidate for use in catalytic reactions that require the selective formation of one enantiomer over another, which is particularly important in the synthesis of enantiomerically pure compounds for pharmaceutical applications.
Used in Organic Synthesis:
Additionally, (S)-1-(pyridin-3-yl)ethanamine dihydrochloride is utilized in organic synthesis for the creation of various organic compounds. Its versatility as a reagent allows for its use in a wide range of reactions, contributing to the development of new molecules with potential applications in various industries, including pharmaceuticals, materials science, and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 40154-84-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,1,5 and 4 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 40154-84:
(7*4)+(6*0)+(5*1)+(4*5)+(3*4)+(2*8)+(1*4)=85
85 % 10 = 5
So 40154-84-5 is a valid CAS Registry Number.
40154-84-5Relevant academic research and scientific papers
Spiro compound
-
Paragraph 0068; 0071; 0074-0075, (2020/07/06)
The invention discloses a spiro compound, application thereof and a pharmaceutical composition containing the spiro compound. The structure of the compound is shown as a formula I, and the compound has a good inhibition effect on RET kinase.
Donor Amine Salt-Based Continuous in situ-Product Crystallization in Amine Transaminase-Catalyzed Reactions
Hülsewede, Dennis,Dohm, Jan-Niklas,von Langermann, Jan
supporting information, p. 2727 - 2733 (2019/05/22)
The unfavorable reaction equilibrium of transaminase-catalyzed reactions is a major challenge for the efficient biocatalytic synthesis of chiral amines. In this study the synthetic utilization of a salt-based, continuous in situ-product crystallization is
